← Back to Search

Other

Microneedling for Burn Scars

N/A
Recruiting
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
16 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks
Awards & highlights

Study Summary

This trial will test whether microneedling, a technique that creates microchannels in the skin, can improve the appearance of hypertrophic scars.

Who is the study for?
This trial is for individuals aged 16 or older with at least two hypertrophic scars from burns, who can consent to treatment. It's not suitable for those with keloid scars, mature scar sites, certain psychiatric or cognitive impairments, skin conditions like psoriasis or eczema near the scar site, allergies to ultrasound gel, language barriers in English or French, or those on anticoagulants.Check my eligibility
What is being tested?
The study tests microneedling's effectiveness on burn-related hypertrophic scars. Microneedling involves an electrical device creating microchannels in the skin followed by cortisone application. The goal is to improve scar pliability, thickness and redness through up to five treatments.See study design
What are the potential side effects?
Microneedling may cause temporary redness, swelling at the treatment site and bruising. There might also be a risk of infection due to skin punctures and increased sensitivity due to cortisone application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 16 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cutometer Skin Elasticity Changes
Skin Erythema Changes
Skin Thickness Changes
Secondary outcome measures
Patient reported effectiveness of intervention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Microneedling treated scarExperimental Treatment1 Intervention
Microneedling
Group II: Control scarActive Control1 Intervention
No intervention, standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Microneedling
2017
Completed Phase 3
~340

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,601 Total Patients Enrolled
2 Trials studying Burn Scars
84 Patients Enrolled for Burn Scars

Media Library

Microneedling (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05423613 — N/A
Burn Scars Research Study Groups: Control scar, Microneedling treated scar
Burn Scars Clinical Trial 2023: Microneedling Highlights & Side Effects. Trial Name: NCT05423613 — N/A
Microneedling (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05423613 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for patients to participate in this research?

"Affirmative. According to clinicaltrials.gov, this medical study is still in need of participants and was originally posted on January 22nd 2021 before receiving its most recent update on June 16th 2022. 36 patients are expected at one site for the duration of the trial."

Answered by AI

What is the current participant enrollment for this clinical experiment?

"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was first announced on January 22nd 2021, is still recruiting patients to participate in the study. In total, 36 participants need to be enrolled at a single medical facility."

Answered by AI

Does this clinical research encompass geriatric participants?

"This trial requires that patients must be at least 16 years of age and not surpass 100 in order to enroll."

Answered by AI

Is there an opportunity to take part in this experiment?

"This medical trial is enrolling 36 individuals aged 16 and over who are suffering from burns. Any gender identity, racial background, or age can be admitted as long as they meet the baseline criteria for HSc and provide written consent."

Answered by AI
~9 spots leftby Jun 2025